Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on the ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

BERNARDSVILLE, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule mRNA drugs and their mechanisms of action by phenotypic screening with AI driven ...

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

BERNARDSVILLE, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leading Tech.Bio in the discovery of mRNA drugs and targets, announced its third webinar, a part of their exclusive LightON ...

As the Trump administration cuts federal funding for mRNA vaccine research, two top scientific efforts in New York are poised to continue forging mRNA-related breakthroughs aimed at fighting diseases ...

The Department of Health and Human Services announced Tuesday that it’s winding down $500 million in funding for the development of mRNA vaccines, which became most widely known during the COVID-19 ...

As president and co-founder of the Global Healthy Living Foundation, I’ve spent more than two decades advocating for people living with chronic disease. In Minnesota alone, we represent over 5,000 ...